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Abstract
The human protein Rad51 is double-edged in cancer contexts: on one hand, preventing tumour-
igenesis by eliminating potentially carcinogenic DNA damage and, on the other, promoting
tumours by introducing new mutations. Understanding mechanistic details of Rad51 in homol-
ogous recombination (HR) and repair could facilitate design of novelmethods, including CRISPR,
for Rad51-targeted cancer treatment. Despite extensive research, however, we do not yet under-
stand the mechanism of HR in sufficient detail, partly due to complexity, a large number of Rad51
protein units being involved in the exchange of long DNA segments. Another reason for lack of
understanding could be that current recognition models of DNA interactions focus only on
hydrogen bond-directed base pair formation. A more complete model may need to include, for
example, the kinetic effects of DNA base stacking and unstacking (‘longitudinal breathing’).
These might explain how Rad51 can recognize sequence identity of DNA over several bases long
stretches with high accuracy, despite the fact that a single base mismatch could be tolerated if we
consider only the hydrogen bond energy. We here propose that certain specific hydrophobic
effects, recently discovered destabilizing stacking of nucleobases, may play a central role in this
context for the function of Rad51.
Causes of cancer
Replication errors
Cancer is a genetic disease in the sense that it is induced by modification of genetic information
(the nucleotide sequence) in genes involved in regulating cell proliferation resulting in uncon-
trolled cell proliferation, a landmark of tumour. Since cell proliferation is tightly regulated by
both negative and positive controls, modification of more than two genes is usually required for
tumour formation. Furthermore, cancer is a malignant tumour with potential of invasion into
healthy tissue and metastasis. Modification of several other genes such as genes involved in
apoptosis, metabolism, cell–cell contact, and so on, is also required for rapid proliferation,
metastasis and escape from immune response (Fig. 1).
Modification could be caused by replication errors; this is, however, very rare because the high
fidelity of DNA replication is maintained by DNA polymerase itself, its proofreading functions
and other surveillance systems such as mismatch-repair systems (Kunkel, 2004; Bębenek and
Graczyk, 2018). Therefore, modification of particular sets of several genes in one cell needs
accumulation of errors upon many cell divisions over the course of a lifespan. Consequently, older
people are more prone to get cancer. However, such events are still very rare under normal
conditions. Loss of replication fidelity due to inherited and sporadic mutations in replication error
repair systems (Bębenek andGraczyk, 2018) is a prerequisite for cancer formation. Individualswith
inherited mutations in mismatch repair enzymes seem prone to developing colorectal cancer.
Another cause that increases replication errors is DNA damage as we will touch upon below.
DNA damage and error-prone repair
DNA damage by exogenous and endogenous agents can result in mutation (De Bont and van
Larebeke, 2004; Tubbs andNussenzweig, 2017). DNA is chemically fragile; every minute in every
cell, it undergoes various chemical modifications, including oxidation, alkylation, deamination,
elimination of nucleobases and disruption of the phosphate backbone (De Bont and van
Larebeke, 2004). Some modifications, such as 8-oxoguanine (8-oxoG) and O-6 methyl guanine
(O6-methylG), increase the likelihood of replication error by forming non-canonical base pairs
(8-oxoG with A and O6-methylG with T). Other modifications are bypassed by less accurate
DNA polymerases (translesion replication), promoting mutation (Sale, 2013).
Cells harbourmultiple redundant DNA repair systems that help them avoid forming tumours
(Sale, 2013). DNA damage that occurs on one of the two DNA strands can be repaired using the
undamaged complementary strand as a template. By contrast, double-strand breaks cannot be
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microhomology-mediated end-joining or homologous recombina-
tion (HR) (Jasin and Rothstein, 2013; Wright et al., 2018). NHEJ is
mutagenic, whereas HR is comparatively error-free (Tubbs and
Nussenzweig, 2017). Inherited and sporadic defects in repair
enzymes predispose carriers to cancer formation, and such muta-
tions are observed in many cancers (Tubbs and Nussenzweig,
2017). Behaviours that cause accumulation of DNA damage, such
as smoking or excessive sun exposure, also increase cancer risk.
HR: double-edged roles
HR involves exchange of strands between two homologous DNAs,
and its main step is catalysed by Rad51 (Jasin and Rothstein, 2013;
Wright et al., 2018). A schematic presentation of the Rad51-
promoted strand-exchange mechanism is given in Fig. 2. By
exchanging a broken strand for an undamaged homologous strand,
HR can repair double-strand breaks usually without causing any
genetic modification and, in this way, prevent mutation. HR also
restores a stalled replication fork due to replication error or non-
treatedDNAdamage. However, the role ofHR in preventing cancer
was underestimated until the discovery that BRCA2, the mutation
of which predisposes to breast and ovarian cancers with high
penetrance (Prakash et al., 2015; Heeke et al., 2018), is involved
in HR by direct interaction with Rad51 (Mizuta et al., 1997).
On the other hand, strand exchange can promote loss of het-
erozygosity and aberrant genetic arrangement (Godin et al., 2016).
In our cells, most genes exist in pairs, one inherited from each
parent. Mutations are rare and usually affect only one copy of a
gene, and it is likely that any given mutation will be masked by the
presence of the ‘healthy’ gene, with the exception of dominant
phenotypes such as predisposition to breast cancer caused by
BRCA2 mutation. Loss of heterozygosity causes the mutant pheno-
type to becomemanifest. Thus, HR can in this way also contribute to
cancer formation (Godin et al., 2016). HR may also occur between
two non-identical but similar DNA parts. This promotes deletion of
DNA, when two parts are on the same DNA and chromosome
translocation when two parts are on two different chromosomes
(Bishop and Schiestl, 2002). These exchanges can occur in human
Fig. 1. Schematic view of available strategies for therapeutic targeting of the various ‘hallmarks of cancer’ with drugs that interfere with each of the acquired capabilities
necessary for tumour growth and progression. Adapted with permission from Hanahan and Weinberg (2012).
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Fig. 2. Schematic presentation of Rad51-promoted DNA strand-exchange reaction.
Reaction steps observed by kinetic analysis (Ito et al., 2018) are shown. Rad51
molecules (green balls) bind to single-stranded DNA (blue line) to form a presynaptic
filament. The filament binds a double-stranded DNA (red/orange lines) to form
complex C1 and changes the DNA conformation (complex C1) before complete strand
exchange. For simplicity, helical shapes of Rad51 filament and double-stranded DNA
are not shown. Structures of C1 and C2 complexes are yet unknown.
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because the human genome is so large that there can bemany similar
DNA sequences. Furthermore, the human genome contains many
repetitive sequences. Therefore ‘erroneous’ HR may be a cause of
cancer formation. In Fig. 3, the origin of the double-edged roles of
Rad51 is schematically presented. Obviously, it is important to
understand in detail the recognition mechanism of homologous
DNA and its accuracy. Such knowledge would be also useful for the
application of the CRISPR technique, which relies on accuracy of HR
to incorporate external DNA at an appropriate site in chromosome.
Rad51 and cancer
Basic functions of Rad51
Rad51 is a member of the RecA family of proteins, which also
includes RecA, RadA andDmc1. It plays a key role in HR: searching
out and pairing homologous DNA sequences and then promoting
strand exchange between them (Fig. 2). Rad51 function in cells
requires several accessory proteins (Bishop and Schiestl, 2002;
Carreira and Kowalczykowski, 2011; Prakash et al., 2015; Heeke
et al., 2018; Jia et al., 2019), and its activity is regulated by the
interactions with regulatory proteins and post-translational modifi-
cations. Rad51 is phosphorylated by cancer-related kinases (Daboussi
et al., 2002; Chabot et al., 2019). Hypoxia in cancer cells is reported to
downregulate Rad51 (Bindra et al., 2004). In addition to defects in the
accessory proteins of Rad51 involved in HR, which are frequently
observed in cancer cells, alterations of Rad51 itself have also been
observed in cancer patients (Antoniou et al., 2008).
Rad51 antagonises radio- and chemo-therapies of cancer
Rad51 is thought to protect cancer cells against radio- and chemo-
therapies by repairing DNA damage induced by these treatments –
‘Rad’ derived from radiation (Prakash et al., 2015). Consequently,
cancers with defects in HR are more efficiently treated by such
therapeutic modalities. In fact, inhibition or downregulation of
Rad51 increases the efficiency of radiotherapy and chemotherapy
(Tsai et al., 2010). In this context, many small molecules that could
act as inhibitors of Rad51 activity are worth investigating (Huang
and Mazin, 2014; Chen et al., 2017).
Rad51 promotes cancer and cancer progression
When overexpressed, Rad51 can also promote cancer, and hyper-
active Rad51 mutations have been detected in the cells of solid
tumours. Multiple studies have reported Rad51 overexpression in
various cancers (Godin et al., 2016). Furthermore, these studies
show that elevated Rad51 expression is correlated with reduced
patient survival. Thus, Rad51 promotes progression of cancer,
increasing its malignancy by stimulating metastasis and increasing
resistance to chemotherapy. Accordingly, Rad51 is considered
promising as a target for treatment of cervical carcinoma, breast
cancer and non-small-cell lung cancer (Tsai et al., 2010; Huang and
Mazin, 2014; Chen et al., 2017; Jia et al., 2019).
Many cancers have epigenetic deficiencies in various DNA
repair genes, likely resulting in higher rates of unrepaired DNA
damage. The overexpression of Rad51 seen in many cancers may
reflect compensatory Rad51 overexpression (as in BRCA1 defi-
ciency) and elevated rates of HR repair to deal at least partially
with excess DNA damage.
Challenge of understanding Rad51-promoted DNA
strand-exchange reaction
Appropriate inhibition of Rad51
As noted above, Rad51 has been proposed as a target for cancer
treatment. Indeed, some Rad51 inhibitors are effective against some
cancers. However, because of the double-edged character of Rad51,
inhibition of its activity may also have negative effects, for example,
promoting more malignant cancers. Many currently available
Rad51 inhibitors prevent formation of Rad51 filament on DNA,
the first step of the reaction (Huang and Mazin, 2014; Chen et al.,
2017). Consequently, damage then remains unaddressed and may
end up being processed by amutagenic repair system such asNHEJ.
Therefore, it would be preferable to inhibit the reaction at an inter-
mediate stage that is toxic to cancer cells. Such toxic Rad51 filaments
have been reported in yeast (Veaute et al., 2003; Symington
and Heyer, 2006). However, it is necessary to fully understand
the reaction mechanism in order to inhibit Rad51 activity at the























Fig. 3. The double-edged roles of Rad51-mediated homologous DNA recombination and associated normal, benign processes in an organism (blue) and below (in red) error-
associated processes potentially connected to tumour formation.
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Rad51 will be crucially needed in future CRISPR-based cancer
therapy
Double-strand-break repair by HR is initiated by 50-to-30 strand
resection; in humans, the DNA nuclease cuts back the 50 end of one
strand to generate a 30 single-stranded DNA overhang. The devel-
opment of CRISPR technology for both cancer gene diagnostics and
therapeutics (including gene-edited T-cells) will rely on insight into
the native cellular repair system. Thismay represent one of themost
importantmotivations for investigating Rad51 (andRecA, asmodel
system) in cancer research.When Aaron Klug invented zinc finger-
based sequence-specific artificial double-strand endonucleases, he
noted that a bottleneck in progress toward gene-correction therapy
would be the need to entrust insertion of the desired DNA into the
native cellular recombination machinery, that is, Rad51 (Deltcheva
et al., 2011; Jinek et al., 2012).
Reaction mechanism
The mechanisms of recombination enzymes appear similar in all
organisms (Ito et al., 2018; Takahashi, 2018). In eukaryotes, the
Rad51 protein plays a central role in homologous recombinational
repair. Specifically, Rad51 catalyses strand transfer between a dam-
aged sequence and its undamaged homologue to allow re-synthesis
of the damaged region. In addition, it collaborates with Dmc1,
another recombinase, in proper segregation of chromosomes in
meiosis. For the reaction, the enzyme binds to a single-stranded
region of DNA to form a well-organized filamentous complex with
DNA (Fig. 2). This single-stranded (ss) DNA–RecA filament then
interacts with a double-stranded (ds) DNA to form an ssDNA–
RecA–dsDNAcomplex, and if the twoDNAshave identical or nearly
identical sequences, strand exchange occurs. All reaction steps occur
in a long nucleoprotein filament.
The structure of ssDNA–RecA filament has been determined by
X-ray crystallographic analysis (Chen et al., 2008) and other tech-
niques such as linear dichroism and electron microscopy (Stasiak
et al., 1981; Norden et al., 1992). The structure of ssDNA–Rad51
filament seems similar (Xu et al., 2017). In the filament, Rad51
monomers are arranged in a helical manner around ssDNA, which
also forms helix and ready to receive dsDNA (Reymer et al., 2009).
DNA is elongated about 50% in length. By contrast, the structure of
ssDNA–RecA–dsDNA (and ssDNA–Rad51–dsDNA) complex has
not been determined although linear dichroism and modeling indi-
cate a similar protein arrangement (Reymer et al., 2009). Kinetic
analysis shows the presence of two ssDNA–Rad51–dsDNA complex
intermediates (Fig. 2) (Ito et al., 2018). Recognition of sequence
homology seems to occur before formation of Watson–Crick base
pairing between ssDNA and complementary strand separated from
dsDNA (Gupta et al., 1999). The reaction can start at any part with
six-base homology (Anand et al., 2017; Takahashi, 2018).
Despite the great importance of recombinases in the context of
human health (e.g. cancer, gene therapy and sterility) and many
years of intense research, the mechanisms of homology search and
strand exchange are not yet understood at the atomic level. Many
questions, including how the Rad51 filament binds a second DNA,
recognizes and searches sequence homology and why Rad51
stretches the DNA, remain unanswered. An improved understand-
ing of the mechanistic details of these fundamental processes could
hopefully clarify the accuracy of HR and its double-edged roles in
both cancer prevention and formation. Such knowledge will also be
useful for the CRISPR technology, in which incorporation of new
DNA relies on the cell’s native recombination machinery.
The lack of breakthroughs in HR research could have several
explanations. One possibility could be the fact that the reaction
differs from many other enzymatic reactions in terms of substrate
size. Rad51 exchanges strands of long DNA segments, and many
Rad51 molecules must assemble into a very long filament to catal-
yse the reaction. Consequently, elucidating reaction mechanisms is
challenging. Furthermore, Rad51 interacts with two DNA mole-
cules to promote strand exchange between them. The details of how
Rad51 interacts with these DNAs, especially the second one, and
associated topological challenges, remain elusive. For example, we
do not know how the second DNA enters the filament to interact
with the first DNA, which is completely coated by Rad51. Similarly,
it remains unclear how Rad51 separates the two strands of double-
stranded DNA to promote strand exchange.
Contributions of other factors than hydrogen bonds to DNA base
pair recognition
A provocative possibility is that our current model of DNA recog-
nition based on hydrogen bonded Watson–Crick base pairs is
somehow incomplete, requiring some new theoretical approach
to guide more systematic experiments. Here key factors including
hydrophobic catalytic effects may have been overlooked. Conven-
tionally, we imagine that the HR in DNA involves the formation of
base pairs mediated by hydrogen bonds between two strands.
However, hydrogen bonding alone cannot explain the discrimina-
tion of DNA with few mismatches relative to a completely com-
plementary strand. Both Rad51 and RecA initiate the HR reaction
when the two DNAs present sequence identity over as many as six
to eight contiguous bases (Anand et al., 2017; Takahashi, 2018). The
energetic difference between binding of DNA with one mismatch
and with a completely matched DNA is too small (less than 20%) if
we consider only hydrogen bond formation between bases. Still
RecAmanages to eliminate such a singlymismatchedDNA inmore
than 80% of the cases (Takahashi, 2018). This may be because the
selection is notmade thermodynamically but kinetically (Bazemore
et al., 1997; Takahashi, 2018). Amatched DNA binds to the Rad51/
DNA filament much faster than one containing a mismatch, as has
also been observed in hybridization contexts (Jensen et al., 1997).
This is apparently also the case with the selection of complementary
base by DNA polymerase during replication (Oertell et al., 2016).
However, the hydrogen bonds become rapidly weaker with dis-
tance, and it is difficult to imagine that hydrogen bonds alone could
play a decisive role in the kinetic selection process.We here propose
that other factors be involved.
We know today that DNA polymerase selects the correct
DNA base without requiring complete hydrogen bond formation
(Kool, 2000), and that certain modified DNA bases that cannot
form hydrogen bonds with a partner are still selected by poly-
merases. Moreover, several studies have reported artificial base
pairs involving non-canonical bases that do not form any hydrogen
bonds with their partners (Henry and Romesberg, 2003; Yamashige
et al., 2012), and that DNA containing such a third base pair
(in addition to A–T andG–C pairs) can still be correctly replicated
without significant error. In these base pairs, geometrical com-
plementarity of two bases appear to be important (Yamashige
et al., 2012). For such a recognition mechanism, also the correct
mutual orientation of the two bases is crucial. This orientation
effect may be the result of a precise steric guidance due to base
stacking with adjacent bases. A similar mechanism, we propose,
may be involved in the Rad51-promoted DNA recognition and
strand exchange.
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The stability of double-stranded DNA is supported mainly
by base stacking between neighbouring bases, rather than by
formation of A–T and G–C base pairs (Yakovchuk et al., 2006).
We recently demonstrated that the semi-hydrophobic environ-
ment created by ethylene glycol ethers, such as poly-ethylene
glycol (PEG), significantly weakens DNA base-stacking strength
but not the hydrogen bonding, and also promotes the DNA
strand-exchange reaction even in the absence of any recombinase
protein (Feng et al., 2019). Interestingly, both RecA and Rad51
elongate DNA by unstacking one base pair of every three, evidenc-
ing a weakening of the base-stacking forces (Chen et al., 2008;
Xu et al., 2017; Sun et al. 2020). Interestingly, we also note that
several hydrophobic residues are present in the proximity of the
DNA-binding sites of both Rad51 and RecA (the so-called L1 and
L2 loops), and, thus, we speculate that these, just like PEG, can
provide a hydrophobic environment that may catalyse the strand-
exchange reaction.
Perspective
Obviously, Rad51 is involved in causing many, possibly a majority,
of our common cancers. At present, however, this is simply a
statement of correlation, and the exact causal mechanism is yet
unknown. It is obvious that dealing with the genome, either by
natural heterozygotic gene mixing, which is the basis of Darwinian
evolution, or the repair of random errors is serious business and
prone to introduce potentially malignant genetic aberrations.
Unsolved questions regarding both the eukaryotic Rad51 and its
simpler, more ‘ancestral’ protein RecA in prokaryotes have per-
sisted despite over 40 years of intense research. This may be partly
explained by the inherent complexity of the HR reaction, which
involves a large number (10–100) of Rad51 protein units bound to a
stretch of DNA. However, it is also possible that our understanding
of recombination mechanisms remains incomplete. One factor
recently proposed to be important for the interactions and stability
of DNA is hydrophobic effects in the vicinity of DNA, which may
be involved in catalysing crucial steps in the HR reaction (Ito et al.,
2018) via a destabilized base stacking (Feng et al., 2019). Such an
effect might explain the bewildering observation that in contrast to
DNA replication and transcription, where nucleotides are added
and tested one by one, homologous DNA recombination through
strand exchange is testing whole sequences, six or more bases in
length, for complementarity, requiring the elimination of partially
mismatched yet thermodynamically stable intermediates. These are
just a few of the elusive points; many questions remain regarding
mechanism of gene recombination. For these reasons, and in light
of the strong connection between cancer and Rad51, we conclude
that fundamental research on Rad51 is a prerequisite for progress in
cancer research.
Open Peer Review. To view the open peer review materials for this
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